Element Biosciences is a company that develops and provides DNA sequencing technology and solutions for genomic research and applications.

Element Biosciences

Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multiomics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.

Janus Henderson Investors

JS Capital Management

Logos Capital

Meritech Capital Partners

Counterpoint Global

Fidelity

Fidelity Management and Research Company

T. Rowe Price

Venrock

RA Capital Management

Foresite Capital

Missed the second installment of our 2024 Shift Your Science webinar series? Watch it now on-demand to delve into the revolutionary AVITI24™ system, redefining sequencing as we know it.

Learn how AVITI24 pushes benchtop sequencing into the next frontier by re-imagining core sequencing components and discover how Teton™ CytoProfiling allows you to analyze DNA, RNA, proteins, phosphorylated proteins, and cell morphology simultaneously, from just one sample in <24 hours.

Watch it now for insights into the future of sequencing! https://bit.ly/3XtcZPk

#ElemBio #AVITI24 #ShiftYourScience #Genomics #Multiomics #Sequencing #BioTech #NGS

We are pleased to announce the closing of our $277m Series D investment round. This funding will support the continued commercialization of AVITI™ and bolster the launch of AVITI24™, our revolutionary multi-omics powered sequencer.

Thank you to our new and existing investors at Wellington Management, Samsung Electronics, Fidelity Investments, Foresite Capital, T. Rowe Price, and Venrock, among others. We are grateful for your support of Element’s mission to empower the scientific community with cutting-edge innovation. https://bit.ly/4f0a4Ue

#ElemBio #AVITI #Innovation #AVITI24 #Sequencing #Genomics #ResearchInnovation #Multiomics #LifeScience

We are pleased to announce Annie K. as the winner 🏆of the AVITI™ for Oncology grant, jointly offered by Element and AmpSeq!  Dr. Kathuria will utilize AVITI sequencing to characterize novel 3D organoid models for biomarker discovery and therapeutic screening. Learn more about AVITI sequencing: https://bit.ly/3Lgrn5R

#ElemBio #AVITI #OncologyGrant #Sequencing #OncologyResearch #CancerResearch

Join us at Single Cell Congress Asia 2024 to explore AVITI24™️, our innovative platform that integrates advanced sequencing and cytoprofiling. Discover how Element's flexible, upgradable systems can enhance your single cell research. Visit Booth 6 to speak with Element & Sciencewerke Pte Ltd representatives to learn more. https://bit.ly/3Ye6n7R

#Singlecell #Elembio #AVITI #AVITI24 #ShiftYourScience #Sequencing #ResearchInnovation #Genomics

🚀 Flexible, high-quality sequencing and cytoprofiling solutions 🚀

The AVITI™ system family empowers researchers with cutting-edge sequencing technology, unparalleled performance, and flexibility to upgrade as your applications and throughput needs grow. 

🧬 AVITI24 combines state-of-the-art sequencing and Teton™ CytoProfiling into a single platform so you can simultaneously analyze DNA, RNA, proteins, and cellular morphology from a single sample.
🧬 AVITI performs cost-effective, high-quality sequencing with a flexible throughput, saving you time and resources.
🧬 AVITI LT is a low-throughput version of AVITI, ideal for smaller-scale projects or labs with a small range of applications or limited capital equipment budget.

🔍 Discover the AVITI family: https://bit.ly/3xGWGnn

#ElemBio #AVITI #AVITI24 #Sequencing #Genomics #GenomeSequencing #ResearchInnovation

Don’t miss the Front Line Genomics webinar series, Multiomics Unleashed to explore the latest advancements in multiomics.

Join us at Webinar 2: Enhancing Your Multiomic Workflows with Data Integration where Abbey Cutchin, Associate Director, Strategic Marketing will share how the AVITI24™ uses Teton™ Chemistry to empower multiomic cytoprofiling and cell analysis.

📅 Tuesday, July 16 2024
🕒 10:00 AM EDT | 3:00 PM BST | 4:00 PM CET

Secure your spot: https://bit.ly/3zt5wFM

#ElemBio #AVITI #Multiomic #AVITI #Genomics #Sequencing #Cytoprofiling #ResearchInnovation

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 12, 2024 8:18 PM	e4fc2ec7
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 13, 2024 2:24 AM	7e20c136
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 12, 2024 8:18 PM	7d782572
translate crunchbase fundingrounds	general
peers	general	Jul 12, 2024 8:18 PM	e0a83e35
news basic	general	Jul 12, 2024 8:18 PM	b1196252
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ELEMENTBIOSCIENCES

Element Biosciences